Oscar Health, Inc. Class A (OSCR)

Oscar Health's stock price has been impacted by several events. In February 2026, the company announced its financial results for 2025 and provided optimistic 2026 revenue guidance, leading to a stock price surge. In October 2025, the stock reached a 52-week high of $22.47. In early April 2026, shares saw a slight increase after CMS finalized its 2027 Medicare Advantage and Part D payment policies. There was also a notable stock decline approximately 21 days before February 10, 2026, due to an institutional investor selling its entire position.

Demand for Oscar Health's products and services exhibits seasonality, primarily driven by the Affordable Care Act (ACA) open enrollment periods. These periods are crucial for individual and family plan sign-ups, leading to significant membership growth. The company's strategic expansions and product launches are often timed to coincide with these enrollment periods.

Oscar Health, Inc. operates in the Financials sector, offering various health plans, including individual and family, Medicare Advantage, and small group plans. Its full-stack technology platform, +Oscar, is licensed to other healthcare organizations. The company uses data and digital tools for a seamless member experience, personalized care, and transparent pricing. Oscar Health has introduced specialized plans and is integrating AI tools like Oswell to enhance customer experience.

Oscar Health's operations are primarily focused within the United States. In 2025, its services were available in 504 counties across 18 states, with plans to expand to 573 counties in 20 states in 2026, including Alabama and Mississippi. The company aims to double its market footprint over three years, targeting expansion to over 150 metropolitan statistical areas by 2027.

Oscar Health has cultivated a brand reputation centered on being a consumer-friendly health insurance company that leverages technology. The company focuses on transparent pricing, personalized support, and a seamless digital experience. In the past year, Oscar Health has emphasized its technology-driven approach, including AI tools like Oswell, and has focused on expanding access to affordable healthcare. While praised for its user interface, it has faced past criticisms regarding network cuts and issues with claim coverage. Recent PR efforts have focused on addressing industry-wide controversies and positioning Oscar Health as part of the solution.

As of April 9, 2025, institutional ownership of Oscar Health, Inc. stood at 77.13%, while insider ownership was 4.05%. Major institutional investors include Vanguard Group Inc., BlackRock, Inc., T. Rowe Price Investment Management, Inc., Morgan Stanley, American Century Companies Inc, BIT Capital GmbH, D. E. Shaw & Co., Inc., Jane Street Group, Llc, Susquehanna International Group, Llp, and State Street Corp. Thrive Capital Management, LLC, linked to co-founder Joshua Kushner, is also a significant founding investor and stakeholder. General Catalyst Group VI LP is noted as the largest individual Oscar Health shareholder.